Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
146.77
-0.98 (-0.66%)
Sep 1, 2026, 1:22 PM EDT - Market open

Protagonist Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
420.08128.3997.25186.73125.74123.67
Short-Term Investments
362.5438.97321.66154.89111.61203.24
Cash & Short-Term Investments
782.58567.36418.91341.62237.36326.9
Cash Growth
37.18%35.44%22.63%43.93%-27.39%6.90%
Accounts Receivable
16.780.12165100.011.57
Other Receivables
2.864.383.490.330.043.77
Receivables
19.644.5168.4910.330.055.33
Prepaid Expenses
2.625.714.243.635.678.5
Other Current Assets
2.31-----
Total Current Assets
807.15577.57591.64355.58243.08340.74
Property, Plant & Equipment
10.411.6912.612.154.636.73
Long-Term Investments
66.8878.64140.25---
Other Long-Term Assets
1.120.290.230.230.230.23
Total Assets
885.54668.19744.73357.95247.93347.7

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.465.341.620.773.641.6
Accrued Expenses
21.4928.0823.6219.2624.5437.31
Current Portion of Leases
2.42.280.511.142.522.2
Current Income Taxes Payable
--2.69---
Current Unearned Revenue
9.669.5518.89--1.6
Other Current Liabilities
0.180.190.070.10.481.31
Total Current Liabilities
37.1845.4447.421.2731.1844.02
Long-Term Leases
6.828.0410.36-1.143.66
Long-Term Unearned Revenue
--11.68---
Total Liabilities
4453.4869.4321.2732.3247.67

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0000--
Additional Paid-In Capital
1,1461,0851,016952.49752.72709.68
Retained Earnings
-304.04-470.67-340.52-615.71-536.76-409.36
Comprehensive Income & Other
-0.830.64-0.08-0.11-0.36-0.3
Total Common Equity
841.54614.71675.3336.68215.61300.02
Shareholders' Equity
841.54614.71675.3336.68215.61300.02
Total Liabilities & Equity
885.54668.19744.73357.95247.93347.7

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
9.2210.3210.871.143.665.86
Net Cash (Debt)
840.24635.68548.3340.48233.7321.04
Net Cash Growth
26.98%15.94%61.04%45.69%-27.21%6.36%
Net Cash Per Share
12.4710.008.436.004.776.93
Filing Date Shares Outstanding
64.7163.8161.3858.2751.2848.41
Total Common Shares Outstanding
64.6762.5861.0457.7149.3447.84
Working Capital
769.97532.13544.24334.3211.9296.72
Book Value Per Share
13.019.8211.065.834.376.27
Tangible Book Value
841.54614.71675.3336.68215.61300.02
Tangible Book Value Per Share
13.019.8211.065.834.376.27
Machinery
9.649.247.86.475.915.18
Leasehold Improvements
2.942.942.420.960.910.88
SEC Filings: 10-K · 10-Q